Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引：12
|
作者：
Pappot, Helle [1 ]
Baeksted, Christina [1 ,2 ]
Knoop, Ann [1 ]
Mitchell, Sandra A. [3 ]
Nissen, Aase [2 ]
Johansen, Christoffer [4 ]
机构：
[1] Rigshosp, Finsen Ctr, Dept Oncol, Copenhagen, Denmark
[2] Danish Canc Soc, Documentat & Qual, Copenhagen, Denmark
[3] NCI, Outcomes Res Branch, Div Canc Control & Populat Sci, Rockville, MD USA
[4] Danish Canc Soc Res Ctr, Unit Survivorship, Copenhagen, Denmark
来源：
BREAST JOURNAL | 2019年 / 25卷 / 02期
关键词：
adjuvant chemotherapy; breast cancer; patient reported outcome; PRO-CTCAE; toxicity; FOLLOW-UP;
D O I：
10.1111/tbj.13204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients' electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.
引用
收藏
页码：269 / 272
页数：4
相关论文
共 50 条
  • [21] A pilot study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a phase I clinical trial
    Qin, Rui
    Dueck, Amylou C.
    Satele, Daniel
    Molina, Julian R.
    Erlichman, Charles
    Basch, Ethan M.
    Sloan, Jeff A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Linguistic validation of the Japanese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Miyaji, Tempei
    Iioka, Yukiko
    Iwase, Satoru
    Goto, Yasushi
    Tsuboi, Masahiro
    Yamamoto, Daigo
    Odagiri, Hiroki
    Tsubota, Yu
    Kawaguchi, Takashi
    Anzai, Natsumi
    Mitchell, Sandra A.
    Basch, Ethan
    Yamaguchi, Takuhiro
    QUALITY OF LIFE RESEARCH, 2016, 25 : 78 - 78
  • [23] Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials Comment
    Basch, Ethan
    Thanarajasingam, Gita
    Dueck, Amylou C.
    CLINICAL TRIALS, 2022, 19 (03) : 274 - 276
  • [24] Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Liu, Lei
    Suo, Tingting
    Shen, Yongqing
    Geng, Cuizhi
    Song, Zhengchuan
    Liu, Fengxia
    Wang, Jianxin
    Xie, Yanli
    Zhang, Yanshou
    Tang, Tiantian
    Zhang, Lina
    Wang, Weina
    QUALITY OF LIFE RESEARCH, 2020, 29 (11) : 3009 - 3015
  • [25] Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Lei Liu
    Tingting Suo
    Yongqing Shen
    Cuizhi Geng
    Zhengchuan Song
    Fengxia Liu
    Jianxin Wang
    Yanli Xie
    Yanshou Zhang
    Tiantian Tang
    Lina Zhang
    Weina Wang
    Quality of Life Research, 2020, 29 : 3009 - 3015
  • [26] Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library
    Shepshelovich, Daniel
    McDonald, Kate
    Spreafico, Anna
    Razak, Albiruni R. A.
    Bedard, Philippe L.
    Siu, Lillian L.
    Minasian, Lori
    Hansen, Aaron R.
    ONCOLOGIST, 2019, 24 (04): : E146 - E148
  • [27] Validation of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women receiving treatment for metastatic breast cancer
    Mitchell, Sandra A.
    Lang, Kathy
    Nichols, Christine
    Clauser, Steven B.
    Federico, Victoria
    Lalla, Deepa
    Tripathy, Debu
    Hurvitz, Sara A.
    Castro, Kathleen M.
    Reeve, Bryce B.
    Rogak, Lauren J.
    Denicoff, Andrea
    Chen, Alice
    Piekarz, Richard
    Bennett, Antonia V.
    Atkinson, Thomas Michael
    O'Mara, Ann M.
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Development of a composite scoring algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Becker, Claus
    Rogak, Lauren J.
    Schrag, Deborah
    Reeve, Bryce B.
    Spears, Patricia
    Smith, Mary Lou
    Gounder, Mrinal M.
    Mahoney, Michelle R.
    Schwartz, Gary K.
    Bennett, Antonia V.
    Mendoza, Tito R.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Abernethy, Amy P.
    Bruner, Deborah Watkins
    Schwab, Gisela
    Atkinson, Thomas M.
    Thanarajasingam, Gita
    Bertagnolli, Monica M.
    Dueck, Amylou C.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S43 - S44
  • [29] Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Cheng KKF
    S. A. Mitchell
    N. Chan
    E. Ang
    W. Tam
    R. Kanesvaran
    BMC Cancer, 20
  • [30] Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Cheng, K. K. F.
    Mitchell, S. A.
    Chan, N.
    Ang, E.
    Tam, W.
    Kanesvaran, R.
    BMC CANCER, 2020, 20 (01)
12345